Skip to main content
  • TAVR Reasonable for Low-Flow, Low-Gradient Aortic Stenosis Low 30-day mortality observed in high-risk group

    Transcatheter aortic valve replacement (TAVR) appeared to be safe in a high-risk group of patients with low-flow, low-gradient aortic stenosis (LFLG-AS), according to the TOPAS-TAVI registry.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details